PubMed HealthSearch

Biomedical subjects

A A Strauss

Publications and source records attributed to A A Strauss.

8 recordsLinked to original sources

Renal calcification incidence in very low birth weight infants.

Serial ultrasound examinations were performed on 31 neonates with birth weights of less than 1,500 g for the detection of renal calcifications. Renal calcifications occurred in 20 (64%) of the infants at a mean age of 39.3 +/- 26.7 days of life. Infants with renal calcifications had shorter gestations (28.2 +/- 1.8 v 31 +/- 1.4 weeks, P less than .004) and lighter birth weights (924 +/- 195 v 1,338 +/- 100 g, P less than .004) than those infants without renal calcifications (n = 11). Furosemide administration was more common in the infants with renal calcifications (65% v 9.1%, P less than .001). The mean total dose of furosemide administered before renal calcifications were noted was 9.59 +/- 7.25 mg/kg. The 20 neonates with renal calcifications had a mean urine calcium level of 12.0 +/- 6.8 mg/kg/24 hours, mean urine calcium to creatinine ratio of 1.32 +/- 1.03 (range 0.3 to 4.45), and a mean alkaline phosphatase concentration of 961 +/- 327 IU. Initial parathyroid hormone levels were not different between the two groups, and subsequent determinations in infants with renal calcifications did not differ significantly from initial values. Renal calcifications are fairly common among very low birth weight infants, particularly in those receiving supplemental calcium and furosemide therapy. Although long-term implications of such findings are not known, close monitoring of renal function by serial determinations of urine calcium and urine calcium to creatinine ratios may identify those infants at risk for renal calcifications.

Calcinosis

Transient plasma cholinesterase deficiency in preterm infants.

Plasma cholinesterase (ChE) activity was determined shortly after birth in 39 healthy preterm and 20 term infants using a commercially available screening assay. 40 samples of adult blood were analyzed for comparison purposes. There were no statistically significant differences in abnormally low enzyme levels in preterm or term infants and adults. Furthermore, in the preterm infants, ChE activity could not be correlated to gestational age, sex or race. Initially low ChE levels rose to normal adult levels within 2 weeks in all but 2 preterm infants. When muscle relaxant use is deemed necessary in hospitalized preterm infants, measurement of enzyme activity or use of drugs other than succinylcholine may be indicated on the basis of transient ChE deficiency.

Adult

Theophylline toxicity in a preterm infant: selected clinical aspects.

A case of parent-induced theophylline toxicity in a preterm infant is described. Despite a theophylline level of 97 mcg/ml no clinical seizure activity was apparent. Pharmacokinetic data suggested that use of oral activated charcoal may have enhanced drug clearance. Further study is necessary before such therapy can be routinely advocated. Additional clinical features are discussed, including avoidance of dosing errors through careful instruction of all caretakers prior to discharge.

Adult

Neonatal manifestations of maternal phencyclidine (PCP) abuse.

Two cases concerning newborn infants whose mothers used phencyclidine (PCP) during pregnancy are described. The neonatal symptoms of maternal PCP abuse were jitteriness, hypertonicity, vomiting, and one case of diarrhea. In both infants, PCP was detected in the urine during the first few days of life. Both infants were successfully treated with phenobarbital but they continued to remain jittery and slightly hypertonic following discontinuation of the therapy. In one case the infant was noted to be microcephalic. In the neonate, the symptoms of maternal PCP abuse are similar to the symptoms of narcotic withdrawal. The diagnosis of PCP effects in the neonate can be confirmed by urinalysis for the drug. The teratogenicity of PCP remains a possibility. The metabolism and treatment of PCP effects in the newborn need further clarification.

Abnormalities, Drug-Induced